EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totaling 6,100 shares, a drop of 96.0% from the March 15th total of 152,986 shares. Currently, 0.2% of the company’s shares are sold short. Based on an average trading volume of 16,120 shares, the short-interest ratio is presently 0.4 days.
EUDA Health Stock Performance
EUDA traded down $0.41 during midday trading on Friday, reaching $6.72. 1,609 shares of the company were exchanged, compared to its average volume of 11,958. EUDA Health has a one year low of $6.42 and a one year high of $86.00. The stock has a market capitalization of $16.93 million, a P/E ratio of -2.80 and a beta of 0.17. The stock’s 50-day simple moving average is $14.04 and its 200 day simple moving average is $36.52.
Analyst Ratings Changes
EUDA has been the topic of several recent research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a report on Wednesday. Zacks Research cut EUDA Health from a “hold” rating to a “strong sell” rating in a report on Monday, March 23rd. Finally, Greenridge Global reduced their target price on EUDA Health from $120.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, March 9th. One analyst has rated the stock with a Buy rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average price target of $55.00.
Hedge Funds Weigh In On EUDA Health
An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health at the end of the most recent quarter. 4.35% of the stock is owned by institutional investors and hedge funds.
EUDA Health Company Profile
EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.
EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.
Featured Stories
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
